Embark Biotech

About:

Embark Biotech is a biotech company identifying cell surface receptors regulating fat tissue calorie-burning and glucose and lipid uptake.

Website: https://embarkbiotech.com/

Top Investors: BioInnovation Institute

Description:

Embark Biotech is an early-stage biotech company that identifies novel cell surface receptors that physiologically regulate fat tissue calorie-burning and glucose and lipid uptake. The company was founded in 2017 and is headquartered in Copenhagen, Denmark.

Total Funding Amount:

10M DKK

Headquarters Location:

Copenhagen, Hovedstaden, Denmark

Founded Date:

2017-01-01

Contact Email:

contact(AT)embarkbiotech.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2021-09-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai